Related Experiment Video
Updated: Jul 4, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis
Connie W Lee1, Christopher M Raskett, Igor Prudovsky
1Department of Cancer Biology and the Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
Abstract:
Despite progress in the management of breast cancer, the molecular underpinnings of clinically aggressive subtypes of the disease are not well-understood. Here, we show that activation of Notch developmental signaling in estrogen receptor (ER)-negative breast cancer cells results in direct transcriptional up-regulation of the apoptosis inhibitor and cell cycle regulator survivin. This response is associated with increased expression of survivin at mitosis, enhanced cell proliferation, and heightened viability at cell division. Conversely, targeting Notch signaling with a peptidyl gamma-secretase inhibitor suppressed survivin levels, induced apoptosis, abolished colony formation in soft agar, and inhibited localized and metastatic tumor growth in mice, without organ or systemic toxicity. In contrast, ER+ breast cancer cells, or various normal cell types, were insensitive to Notch stimulation. Therefore, ER- breast cancer cells become dependent on Notch-survivin signaling for their maintenance, in vivo. Therapeutic targeting of this pathway may be explored for individualized treatment of patients with clinically aggressive, ER- breast cancer.
Insights
Estrogen receptor-negative breast cancer cells rely on Notch-survivin signaling for survival. Inhibiting this pathway halts tumor growth and induces apoptosis, offering a potential targeted therapy for aggressive breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Estrogen receptor-negative (ER-) breast cancer represents a clinically aggressive subtype with poorly understood molecular drivers.
- Understanding the molecular mechanisms is crucial for developing effective targeted therapies.
Purpose of the Study:
- To investigate the role of Notch signaling in ER- breast cancer.
- To determine the relationship between Notch signaling and survivin expression.
- To evaluate the therapeutic potential of targeting the Notch-survivin pathway.
Main Methods:
- Analysis of Notch signaling activation in ER- breast cancer cells.
- Assessment of survivin (apoptosis inhibitor and cell cycle regulator) expression.
- Inhibition of Notch signaling using a gamma-secretase inhibitor in vitro and in vivo.
- Evaluation of tumor growth, apoptosis, and toxicity in mouse models.
Main Results:
- Notch signaling activation up-regulates survivin transcription in ER- breast cancer cells.
- Targeting Notch signaling suppresses survivin, induces apoptosis, and inhibits tumor growth in mice.
- ER+ breast cancer cells and normal cells are insensitive to Notch stimulation.
- Therapeutic inhibition showed no organ or systemic toxicity.
Conclusions:
- ER- breast cancer cells exhibit a dependency on Notch-survivin signaling for their maintenance.
- Targeting the Notch-survivin pathway is a promising strategy for individualized treatment of aggressive ER- breast cancer.
More Related Videos
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways

